Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
2.970
+0.120 (4.21%)
Aug 13, 2025, 4:00 PM - Market closed
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $44.62 million as of August 14, 2025. Its market cap has decreased by -85.64% in one year.
Market Cap
44.62M
Enterprise Value
7.26M
1-Year Change
-85.64%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $44.62M, a decrease of -63.65%. That is a compound annual growth rate of -16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 42.81M | -86.65% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | 125.13M | 1.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| Novartis AG | 234.72B |
| AstraZeneca | 232.33B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |